0 Comentários
0 Compartilhamentos
149 Visualizações
0 Anterior
Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
-
Faça Login para curtir, compartilhar e comentar!
-
Is RNA Therapeutics Leading the Next Wave of Biopharmaceutical Innovation?Key Drivers Impacting Executive Summary RNA Therapeutics Market Size and Share CAGR Value This global RNA Therapeutics Market research report carries out the methodical and comprehensive market research study that puts forth the facts and figures linked with any subject about RNA Therapeutics Market The forecast, analysis, evaluations, and estimations carried out in this RNA...0 Comentários 0 Compartilhamentos 106 Visualizações 0 Anterior
-
Is the Global RNA Therapeutics Market Driving the Next Wave of Biopharmaceutical Innovation?Key Drivers Impacting Executive Summary RNA Therapeutics Market Size and Share CAGR Value During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 13.20%, primarily driven by the advancements in mRNA technology, increasing prevalence of chronic diseases, and rising investments in personalized medicine This global RNA Therapeutics Market...0 Comentários 0 Compartilhamentos 220 Visualizações 0 Anterior
-
South Korea Biologic Therapy Market Forecast: Toward Global Leadership in Biopharmaceutical InnovationThe South Korea Biologic Therapy Market forecast indicates exponential growth through 2035, driven by expanding R&D investment, digital healthcare adoption, and robust export demand. Future Market Outlook Forecasts suggest a strong CAGR through the next decade as biologics surpass traditional small-molecule drugs in both value and volume. Government-backed initiatives target biosimilar...0 Comentários 0 Compartilhamentos 2K Visualizações 0 Anterior
-
Herpes Simplex Virus (HSV) Vaccines Market Reaching USD 1,360 Million by 2034According to a new report from Intel Market Research, the global Herpes Simplex Virus (HSV) Vaccines market was valued at USD 865 million in 2024 and is projected to reach USD 1,360 million by 2034, growing at a robust CAGR of 6.8% during the forecast period (2025–2034). This growth is driven by the increasing global prevalence of HSV infections, rising awareness about sexually...0 Comentários 0 Compartilhamentos 83 Visualizações 0 Anterior